| EPA054 | Memory CD4 T cells from the liver are infected during SIV infection in Rhesus Macaques | E-poster | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
| EPA055 | Characterization of Hiv-1 intact and near-full length defective proviral populations during long-term suppression on antiretroviral therapy | E-poster | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
| EPA056 | An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixes | E-poster | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
| EPA057 | Viral genome-intactness bioinformatics for subtype A1 and D HIV-1 | E-poster | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
| EPA058 | Rufinamide-induced autophagy cell death in HIV-1-infected macrophages | E-poster | Strategies to reduce/eliminate viral reservoirs |
| EPA059 | Effect of novel latency reversal agents on transposable element expression profile in T-cell memory subsets of HIV clinical samples | E-poster | Strategies to reduce/eliminate viral reservoirs |
| EPA060 | Off-target effects on retroelement expression in T-cells Treated with Histone deacetylase inhibitors | E-poster | Strategies to reduce/eliminate viral reservoirs |
| EPA061 | Nanoparticle delivery of romidepsin to reverse HIV latency | E-poster | Strategies to reduce/eliminate viral reservoirs |
| EPA062 | Gamma/Delta T cells target latently HIV-infected non-T cell reservoirs | E-poster | Strategies to reduce/eliminate viral reservoirs |
| EPA063 | Enhanced functional cytotoxic cell populations in PBMCs from individuals with HIV on treatment with ART and dasatinib | E-poster | Immunotherapy (including broadly neutralizing antibodies) |